Brief: Tenaya Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
19/11/2024 13:15
Nov 19 (Reuters) - Nasdaq Inc NDAQ.O :
* TENAYA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ
LISTING RULE 5635(C)(4)
Source text: ID:nGNX4PVLGh
Further company coverage: NDAQ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027